COMPREHENSIVE COMPARATIVE EFFECTIVENESS AND SAFETY OF FIRST-LINE ANTIHYPERTENSIVE MONOTHERAPY IN HYPERTENSIVE PATIENTS: A LARGE-SCALE MULTINATIONAL PARTICIPANT-LEVEL ASSESSMENT

被引：0
|
作者：
Lu, Yuan [1 ]
Khera, Rohan [1 ]
Liu, Yuntian [1 ]
Chen, Ruijun [1 ]
Schuemie, Martijn [1 ]
Hripcsak, George [1 ]
Suchard, Marc [1 ]
Krumholz, Harlan M. [1 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1577 / 1577
页数：1
相关论文
共 23 条
  • [21] Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
    Pappas, Dimitrios A.
    St John, Gregory
    Etzel, Carol J.
    Fiore, Stefano
    Blachley, Taylor
    Kimura, Toshio
    Punekar, Rajeshwari
    Emeanuru, Kelechi
    Choi, Jeannie
    Boklage, Susan
    Kremer, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01) : 96 - 102
  • [22] Correspondence to 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'
    Zheng, Wenjie
    Leong, Pui-Ying
    Wei, James Cheng-Chung
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11)
  • [23] Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al
    Pappas, Dimitrios A.
    St John, Gregory
    Etzel, Carol J.
    Fiore, Stefano
    Blachley, Taylor
    Kimura, Toshio
    Punekar, Rajeshwari
    Emeanuru, Kelechi
    Choi, Jeannie
    Boklage, Susan
    Kremer, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11)
123